ALK and small cell lung carcinoma: Moreover, at subsequential analyses via fluorescence in situ hybridization (FISH) and PCR performed in ALK-expressed SCLC, no activating alterations (rearrangements, point mutations, or amplification) were detected, and in the cases where copy number gains were shown (4/12), they were mild, accounting for 3–5 copy increases.